Anti-Leishmania major Properties of Nuphar lutea (Yellow Water Lily) Leaf Extracts and Purified 6,6′ Dihydroxythiobinupharidine (DTBN)

Bibliographic Details
Title: Anti-Leishmania major Properties of Nuphar lutea (Yellow Water Lily) Leaf Extracts and Purified 6,6′ Dihydroxythiobinupharidine (DTBN)
Authors: Orit Shmuel, Aviv Rasti, Melodie Zaknoun, Nadav Astman, Avi Golan-Goldhirsh, Orly Sagi, Jacob Gopas
Source: Pathogens, Vol 13, Iss 5, p 384 (2024)
Publisher Information: MDPI AG, 2024.
Publication Year: 2024
Collection: LCC:Medicine
Subject Terms: Leishmania major, cutaneous leishmaniasis, 6,6′-dihydroxythiobinupharidine (DTBN), Nuphar lutea, anti-Leishmania small molecule, Medicine
More Details: Cutaneous leishmaniasis (CL) is a zoonotic disease, manifested as chronic ulcers, potentially leaving unattractive scars. There is no preventive vaccination or optimal medication against leishmaniasis. Chemotherapy generally depends upon a small group of compounds, each with its own efficacy, toxicity, and rate of drug resistance. To date, no standardized, simple, safe, and highly effective regimen for treating CL exists. Therefore, there is an urgent need to develop new optimal medication for this disease. Sesquiterpen thio-alkaloids constitute a group of plant secondary metabolites that bear great potential for medicinal uses. The nupharidines found in Nuphar lutea belong to this group of compounds. We have previously published that Nuphar lutea semi-purified extract containing major components of nupharidines has strong anti-leishmanial activity in vitro. Here, we present in vivo data on the therapeutic benefit of the extract against Leishmania major (L. major) in infected mice. We also expanded these observations by establishing the therapeutic effect of the extract-purified nupharidine 6,6′-dihydroxythiobinupharidine (DTBN) in vitro against promastigotes and intracellular amastigotes as well as in vivo in L. major-infected mice. The results suggest that this novel anti-parasitic small molecule has the potential to be further developed against Leishmania.
Document Type: article
File Description: electronic resource
Language: English
ISSN: 2076-0817
Relation: https://www.mdpi.com/2076-0817/13/5/384; https://doaj.org/toc/2076-0817
DOI: 10.3390/pathogens13050384
Access URL: https://doaj.org/article/b53bdf13b5024b84ba4822b1c23a145f
Accession Number: edsdoj.b53bdf13b5024b84ba4822b1c23a145f
Database: Directory of Open Access Journals
More Details
ISSN:20760817
DOI:10.3390/pathogens13050384
Published in:Pathogens
Language:English